By increasing the surface-bound immunogenic cell death marker levels, like calreticulin (CRT) and HSP70, the gas plasma treatment indirectly triggers the host antitumor immunity, e.g., enhanced tumor cell uptake by macrophages [35, 36]. Here, CALR is linked to neoplasm.